Skip to main content
. 2020 Dec 18;16(5):1341–1356. doi: 10.1007/s11739-020-02589-5

Fig. 3.

Fig. 3

Forest plots evaluating the effect of SMI on overall survival in advanced HCC patients undergoing sorafenib treatment (a) HR from univariate analysis (b) HR from multivariate analysis. CI confidence interval; HCC hepatocellular carcinoma; HR hazard ratio; IV inverse variance; SMI skeletal muscle index